TB Alliance is governed by a Board of Directors, representing global perspectives and expertise in diverse areas of interest that ensure the success and sustainability of the organization.

Dr. Eric Goosby Professor of Medicine & Director of Global Health Delivery and Diplomacy
Ms. Rasha Hibri Chief Financial Officer at the Clinton Health Access Initiative (CHAI)
Mr. Sundar Kodiyalam Co-founder, Vatera Healthcare Partners
Mr. David Norton Board Chair Retired, Former Company Group Chairman, Global Pharmaceuticals, Johnson & Johnson
Dr. Ariel Pablos-Méndez Vice Chair Professor of Medicine, Columbia University Medical Center
Dr. Mario Raviglione Professor of Global Health at the University of Milan, Italy & Former Director of the Global Tuberculosis Programme at the World Health Organization (WHO)
Ms. Kim Schwartz Senior Vice President and Chief Financial Officer at Population Services International
Dr. Melvin Spigelman President & Chief Executive Officer, TB Alliance
Mr. Mitchell Warren President, TB Alliance Stakeholders Association Executive Director, AVAC
Ratan Watal Chairman, Central Vista Oversight Committee, Ministry of Housing and Urban Affairs, India

Our Pipeline

TB Alliance manages the largest pipeline of new TB drugs in history.

View the portfolio